- Microdose Psychedelic Insights will host the upcoming Psychedelic Capital: August 2021 conference on August 31, 2021
- Part of a dedicated investor conference series, the conference will host presentations from companies within the functional mushrooms, and psychedelic-based medical therapies sectors
Microdose Psychedelic Insights (“Microdose”) will host their virtual Psychedelic Capital: August 2021 conference on August 31, 2021. The event will play host to a number of companies from across the psychedelics industry, including, but not limited to, the functional mushrooms and phytopharmaceutical sectors.
Microdose Psychedelic Insights, a cutting-edge media company focused on creating content, financial analysis, and engaging events in the psychedelics industry, is quickly establishing itself as the industry-leader by using its unique vision and innovative events to help shift the global perception of psychedelic medicine.
Part of an investor conference series diving deep into psychedelic medicine investment, Microdose’s Psychedelic Capital conference seeks to introduce investors and attendees to a curated group of CEOs, capital advisors and investment luminaries from around the world. This year’s August conference will be inaugurated by an introductory talk, delivered by Patrick Moher, CEO of Microdose Psychedelic Insights; and Richard Skaife, founding partner at The Conscious Fund, an early-stage venture capital investor within the plant powered medicine sector.
The conference will also showcase a number of corporate presentations from companies focused on medicinal mushroom products, the cultivation and processing of pharmaceutical and medicinal cannabis, psychedelic-based
In addition, the event will also feature an exciting roundtable symposium centred around the latest ongoing developments and breakthroughs in the global psychedelics industry. Other panel topics being discussed in this edition of Psychedelic Capital are Big Boards and Diversity & Inclusion.
An example of one of this month’s panels is
Two Eyed Seeing: Bridging Western Science and Indigenous Wisdom. From Steven Huang (he/him), Founder of Millennial HR Design: “Two-eyed seeing is a Mi’kmaw principle for mindfully bringing together Western science and Indigenous wisdom, using all our understandings so we can leave the world a better place. We’ll discuss how cross-cultural collaboration – across the diverse array of psychedelic stakeholders – could be the key to unlocking tremendous value and growth in an ethical, responsible way.”
“Microdose is proud to host this important discussion regarding Indigenous wisdom and cross-cultural collaboration in the psychedelic medicine space. We strive to create safe, accessible and inclusive events for all—and partner with organizations who are advancing diversity and equity in psychedelics.”- Cristina Cassen, Chief of Staff, Microdose Psychedelic Insights
For more information regarding the details of the event, please visit
https://ibn.fm/5t3Dt
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork.